Nasdaq
$1.77▼ 0.51%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $126.7MShares out 71.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
2- 8.10After-hours26.08.11 05:1910-QEarnings#●●●#●●●
Nkarta, Inc.
엔카타(Nkarta, Inc.)는 2026년 6월 30일 기준 2분기 실적 보고서(10-Q)를 제출했습니다. 2026년 8월 5일 기준 발행주식 총수는 71,624,791주이며, 비임원 이사에 대한 보상 정책을 개정하여 이사 보상 및 주식 매수 선택권 부여 기준을 확정했습니다.…more
$1.77-0.51%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.10After-hours26.08.11 05:128-KKey event
Nkarta, Inc.
엔카타(Nkarta)는 2026년 2분기 4,040만 달러의 순손실(주당 0.54달러)을 기록했으며, 6월 30일 기준 2억 4,320만 달러의 현금 및 투자 자산을 보유하고 있습니다. 현재 NKX019 임상 시험(Ntrust-1, Ntrust-2)이 40억 세포 용량 수준에서 진행 중이며, 확보된 자금으로 2029년까지 운영이 가능할 것으로 예상됩니다.…more
$1.77-0.51%vs prev closeView filingShare
1 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.10Pre-market26.09.10 20:00#●●●#●●●
Nkarta to Participate in September Investor Conferences
Nkarta announced its participation in the upcoming H.C. Wainwright and Stifel investor conferences in September. This is a routine corporate event announcement with no immediate impact on the stock price.…more
$1.77-0.51%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.8Pre-market26.09.08 20:05
●●●●●●●● ●●●●● ●●●●●●
Nkarta will present three abstracts on NKX019, including phase 1/2 safety and efficacy data, at the ACR Convergence 2026 conference. Investors should monitor the upcoming clinical results for further developments in the company's pipeline.…more
$1.77-0.51%vs prev closeShareBenzinga - 9.8Pre-market26.09.08 20:00
●●●●●●●● ●●●●● ●●●●●●
Nkarta announced it will present initial clinical safety and efficacy data for its autoimmune therapy candidate, NKX019, at the upcoming ACR Convergence 2026. This presentation focuses on early-stage clinical findings rather than regulatory approval or immediate commercial impact.…more
$1.77-0.51%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report